Introduction
Low molecular mass GTPases constitute a superfamily that, when in the active conformation (bound to GTP), transduces signals regulating many cellular processes, including morphology, motility, proliferation, gene expression and cytokinesis. When bound to GDP, these proteins are in an inactive state. The family members can be subdivided, on the basis of sequence homology, into ®ve classes: Ras, Rab, Arf, Ran, and Rho. Ras family members play salient roles in cell growth and development (Denhardt, 1996; Malumbres and Pellicer, 1998) . The members of the Rab and Arf subfamilies monitor and direct the movements of vesicles within the cell. Ran is required for nuclear protein import. And ®nally, the Rho family members (Cdc42, Rac, Rho and TC10) play dynamic roles in the regulation of the actin cytoskeleton and cell morphology (Vojtek and Cooper, 1995) . The most studied among these molecules are the proteins encoded by the ras gene family. Members of this subfamily are Ras, RRas, Ral (A and B), Rap, and TC21 .
Ras actions are mediated through interaction with multiple eectors . Known directly interacting molecules include Raf-1, the Ralspeci®c guanine nucleotide exchange factors (RalGEFs) and the p110 subunit of phosphatidyl inositol-3-phosphate kinase (PI3-K) . The best known eectors of Ras are Raf-1 and its close relatives B-Raf and A-Raf. They are serine threonine kinases that become activated by translocation to the plasma membrane and a secondary phosphorylation. Activation of Raf initiates a kinase cascade involving MEK and ERK proteins (Denhardt, 1996) . On the other hand, RalGEFs are Ras eectors and activate, at least, Ral proteins. However, although Ral is a downstream element in Ras-mediated signaling (Wolthuis et al., 1998b) , the activation of Ral is controlled by both Ras-dependent and Ras-independent events (Bos, 1998) . Ral GTPases may in turn regulate the activity of two signaling molecules. One is RalBP1, a GTPase-activating protein for Cdc42 and Rac1 that was also found to form a complex with Pob1 or with Reps (Cantor et al., 1995; Yamaguchi et al., 1997; Ikeda et al., 1998) . Another route where Ral might be involved is in the activation of phospholipase D .
The members of the Ras family of GTPases cycle between the active GTP-bound and inactive GDPbound states. This cycle is maintained by speci®c GEFs and GTPase-activating proteins (GAPs) (Boguski and McCormick, 1993; Bos, 1997) . GEF proteins mediate signal transduction by inducing the dissociation of GDP from the corresponding GTPases, therefore facilitating their binding to GTP (in excess in the cytoplasm) and consequently driving their activation. Deregulation or overexpression of members of the GEF family activate their corresponding GTP-binding proteins mimicking some of the eects of some of the activating mutations, increasing the activation of the substrate molecule (Quilliam et al., 1995) .
Rgr is an oncogene that has been recently isolated in our laboratory by its ability to produce tumors in the nude mice assay (D'Adamo et al., 1997) . This protein was part of the Rsc fusion product identi®ed from a DMBA-induced rabbit squamous cell carcinoma. It appears to be truncated at the 5' end, and fused to another gene, rHHR23A, the rabbit homolog of Rad23. Rgr belongs to the GEF family, also called GDP-dissociation stimulator (GDS) family, and it has signi®cant homology to RalGDS (Ral guanine dissociation stimulator), a molecule that has been shown to be an eector of Ras and that it may functionally link Ras with other Ras-related proteins (White et al., 1996) . Like RalGDS, Rgr has been shown to have speci®c exchange activity on Ral, although unlike RalGDS it lacks the Ras-interacting domain present in the carboxyterminal end of the other family members (D'Adamo et al., 1997) .
Our analysis of the Rgr oncogene in this report has focused on some of the crucial signal transduction pathways induced by this Ral guanine exchange factor in the process of eliciting proliferation, cell transformation and gene expression.
Results

Rgr expression induces phenotypic changes in NIH3T3 cells
In order to determine the cellular eects of the 5'-truncated Rgr oncogene we have constructed NIH3T3 cell lines in which the expression of rgr can be controlled by the concentration of tetracycline in the medium. NIH3T3 cells were cotransfected with pUHD15.1neo-Rgr and pUHD10.3hyg. Clones resistant to G418 and hygromycin were selected. The tTA inactivation studies were carried out with 1 mg of tetracycline per ml in the cultured medium. At this tetracycline concentration full inactivation of tTA was achieved, whereas no change in growth behavior or morphology of NIH3T3 cells occurs. Four clones (TetRgr 4, 16, 17, and 21) with diverse Rgr levels of expression were selected to be expanded as cell lines. As shown in Figure 1 a rapid reduction of Rgr mRNA levels was observed when tetracycline was added to the fully active tetracycline free system: within 24 h, their RNA levels dropped dramatically in the four clones selected. Rgr-expressing cells are small, refractile, and have lost density dependent growth control, whereas tetracycline-cultured cells remain¯at, nonrefractile and grew only as a monolayer. Moreover, the phenotype of these cell lines grown with conditioned media coming from Rgr-expressing cell cultures, and in the presence of tetracycline, remained untransformed. This fact is consistent with a Rgr direct eect on cell behavior and indicates that the Rgr transformation process is unlikely due to autocrine or paracrine eects (Figure 2 ).
Growth transformation is usually associated with changes in the pattern of the actin cytoskeleton organization. Because Rgr caused abnormal cellular morphologies, we next analysed the cytoskeletal organization of cells expressing the oncogene. NIH3T3 cells and Rgr-expressing cells were ®xed and stained with rhodamine-labeled phalloidin. Rgr-expressing ®broblasts show a large increase in the number of stress ®bers (Figure 3 ). These well-developed actin ®bers suggests that Rho may play a part in Rgrinduced transformation, and indicates that Rgr causes tumorigenic transformation without causing a concomitant loss of actin cytoskeletal organization.
Rgr alters the cellular growth properties and induces transformation
In order to address the importance of the Rgr activated pathways in proliferation and cell transformation, we characterized the growth properties of Rgr-stably expressing cell lines. In the presence of growth medium supplemented with 10% serum, the cells expressing Rgr displayed enhanced proliferation when compared to tetracycline-treated cells (Figure 5a ). Analysis of cell cycle distribution by¯ow cytometry showed that the percentage of cells in S phase was signi®cantly greater in asynchronous Rgr-expressing cell cultures ( Figure  4a ). This observation indicates that Rgr promotes G 1 phase progression. To further study the eects of Rgr on cell cycle, tetracycline or ethanol treated TetRgr16 cells were serum starved for 48 h in order to synchronize the cultures. As indicated in Figure 4b , Rgr-expressing cells were slightly less sensitive to the Then, the medium was replaced with fresh complete medium, with (*, control) or without (*, Rgr) tetracycline. At the indicated times after serum replacement, the relative DNA content was assessed by ®xing the cells with 70% ethanol, staining them with propidium iodide (50 mg/ml), and analysing them by¯ow cytometer. The percentage of cells in G 0 /G 1 phase, in S phase, and in G 2 / M phase are shown in b ± d, respectively. This is a representative observation out of three experiments that produced similar results lack of serum than control cells. Whereas 80% of the control cells remained in G 0 /G 1 after 48 h of serum deprivation, only 70% of Rgr expressing cells stopped at this point. This fact corroborates that Rgr can promote reduced serum dependence growth (D'Adamo et al., 1997) . Whereas there were no dierences in the length of the S and G 2 /M cell cycle phases during 22 h after serum exposure (Figure 4c,d) , an increase in the number of cells in the S phase could be observed in the Rgr-expressing cell cultures when compared with control cell cultures (Figure 4c ). This increase was not due to a defective synchronization of the Rgrexpressing cell cultures, because during the ®rst 12 h the number of cells in the S phase were the same in both experimental conditions. This result con®rms that Rgr stimulates proliferation by inducing the entrance of the cells into the S phase.
In addition, Rgr-expressing cells grew to higher saturation density compared to control cells ( Figure  5b ). These results indicate that constitutive expression of Rgr in NIH3T3 ®broblasts causes an increase in the growth rate and a partial loss of contact inhibition.
To con®rm that Rgr acts as a classical oncogene, NIH3T3 cells were transfected either with the Rgr expression plasmid or with the control empty vector. As shown in Figure 5c ,d, the Rgr-transformed cells were able to induce foci with refractile and rounded cells and high cell density at the center of the focus.
Downstream effectors of Rgr action: transcriptional induction of the serum response element and c-Jun
It has been suggested that RalGEFs exert some of their biological and transforming eects by stimulating the promoter activity of growth regulatory genes, such as fos (Murai et al., 1997; Wolthuis et al., 1997) . The c-fos promoter contains a serum response element (SRE), on which factors including the serum response factor (SRF) and ternary complex factor (TCF) combine to form a ternary complex (Shaw et al., 1989) . In this complex, TCF, which comprises members of a small family of Ets domain proteins, including Elk-1, Sap-1 and Sap-2/Erp/Net, contacts an Ets recognition motif adjoining the SRF-binding site (Treisman, 1994) . Elk-1 and Sap-1 are substrates for ERK, JNK and p38 MAPKs and their phosphorylation enhance their transcriptional activity (Price et al., 1995) .
As Figure 6a shows, Rgr expression induces the activation of a SRE luciferase reporter plasmid in cell lines expressing Rgr under the tetracycline controlled promoter as well as in NIH3T3 and 293T cells transiently expressing Rgr. To verify that the SRE induction in the TetRgr cell lines is due to the Rgr expression (in the ethanol treated cells) and not to the tetracycline repression eect (in the control cells), NIH3T3 cells transfected with the SRE luciferase reporter were treated either with ethanol vehicle or with tetracycline. These treatments by themselves had no eect on the studied transcriptional activity (data not shown).
The increase in the SRE transcriptional activity could be due to an enhanced transcriptional activity of the cJun activation domain. We analysed this possibility by transiently transfecting both TetRgr16 and NIH3T3 cells with a chimeric expression vector containing the Gal4 DNA binding domain fused with the c-Jun activation domain (Gal4-Jun), and a luciferase reporter gene containing ®ve Gal4 DNA binding sites (pG5E1b-Luc). Rgr-expressing cells exhibited a markedly greater stimulation of the activation domain of c-Jun than the non expressing cells (Figure 6b ).
Rgr activates MAPKs
Multiple downstream events have been implicated in oncogenic mediated cellular transformation and induction of the gene expression. In fact, the full transformation process is usually dependent on more than one signal transduction pathway (White et al., 1995) . To dissect the pathways that Rgr uses to induce cellular transformation and SRE transcriptional activation we investigated whether this oncogene can in¯uence the activity of the most important signal transduction pathways. Therefore we performed Western blotting of extracts prepared from cells transformed by Rgr and we determined the phosphorylation levels of dierent kinases involved in signal transduction.
Consistent with the increased c-Jun activity, this assay demonstrated that the phosphorylation of both JNK and p38 kinases was eciently enhanced in Rgrexpressing cells, whereas Rgr-silent cells contained low levels of these activated forms (Figure 7a, b) .
Since SRE activation could be also the result of the activation of the ERKs, we also examined whether these kinases were induced by Rgr in parallel with JNK and p38 MAPKs. To detect activation of endogenous ERKs we used an antibody which selectively recognizes the activated phosphorylated forms of ERK1 and ERK2. As Figure 7c shows, Rgr-expressing cells displayed an increase in the levels of activated ERKs compared to control cells (rgr-repressed cells). Total levels of cellular ERK were equivalent among both experimental conditions (Figure 7d ).
These results indicate that Rgr could aect signal transduction pathways that have been shown to display a powerful oncogenic activity.
Rgr activates Ral and Ras
Previous studies from our laboratory demonstrated that Rgr has speci®c exchange activity for Ral in vitro (D'Adamo et al., 1997). However, the above experiments suggested that Rgr was activating not only Ral, but also Ras mediated pathways. Therefore, we proceeded to con®rm the previous results by measuring the active state of these two GTPases. To this end, we used eectors for Ras or Ral as anity reagents to measure the content of GTP-Ras or GTP-Ral in Rgr expressing cells. As Figure 8 shows, whereas the control cells had the same amount of total GTPases, only Rgr expressing cells presented detectable amounts of both active forms, GTP-Ral and GTP-Ras. This activation of Ras by Rgr can account for the enhanced ERK phosphorylation and could explain the powerful transforming potential triggered by this oncogene.
Evaluation of the contribution of the different pathways to Rgr effects
The next goal of our investigation was try to con®rm the role of the dierent pathways by a complementary Figure 6 Transcriptional activation of SRE and c-Jun by Rgr. Dierent cell lines were transfected with 3 mg of SRE-Luc (a) or with 300 ng of Gal4-Jun expression vector plus 3 mg of pG5E1b-Luc as reporter plasmid, as explained in Figure 10b . TetRgr16 cell line was transfected with the corresponding reporter vectors in the presence of tetracycline (control) or vehicle (Rgr). NIH3T3 and 293T cells were cotransfected either with empty vector (control) or with the Rgr-expression vector (Rgr) and with the reporter vectors. Results are means+s.e. from triplicate determinations. The experiment was repeated at least three times. Transfection eciencies were normalized by b-galactosidase activity approach to evaluate their respective contribution to the phenotype, to analyse how Rgr triggers SRE transcriptional activation and to assess Rgr mechanism of cellular transformation.
As previous results from our laboratory linked Rgr to the Ral pathway, we investigated whether Ral is necessary for Rgr-induced SRE activity. To study this possibility, TetRgr16 cells were transiently transfected with the RalN28 expression plasmid, a dominant negative mutant of Ral that is constitutively GDPbound. This mutant binds to and traps endogenous RalGEFs (Wolthuis et al., 1997) . As shown in Figure  9a , SRE driven transcription was impaired but not abolished by this dominant negative form of Ral. NIH3T3 cells cotransfected with Rgr and with RalN28 con®rmed that the stimulatory eect of Rgr could be aected by the dominant negative Ral mutant ( Figure  9b ).
Since we had observed changes in the cytoskeleton suggesting a potential involvement of Rho, we next asked whether the response of the SRE to Rgr might be mediated by this small GTPase. SRE promoter constructs that lack the TCF-binding site but contain the SRF binding site can still be activated not only by Ras, but also by at least two other pathways, involving the Rho family of GTPases (Hill et al., 1995) . This possibility was analysed by testing the ability of RhoA19N to block the response of SRE to Rgr. TetRgr16 cells transfected with this dominant negative form of Rho, and NIH3T3 transiently cotransfected with Rgr and Rho19N, showed a signi®cant, but not complete, impairment of the luciferase expression ( Figure 9a and b, respectively). This result supports some role for Rho in the Rgr mediated signal suggested by the immuno¯uorescence analysis ( Figure  3) .
It has been reported that the activation of the serum response element by the active Rlf, another member of the RalGDS family, is independent of ERK activation (Wolthuis et al., 1997) . Therefore we investigated if this was also true in the case of Rgr by inhibiting the molecules in the pathway with their dominant negative forms. As Figure 9c shows, transfection of TetRgr16 cells with the dominant negative ERK1/2, MEK and Raf1 mutants dramatically reduced the induction of the SRE driven reporter in response to Rgr. Transient cotransfection assays using NIH3T3 and 293T cells yielded similar results (Figure 9d,e) . The speci®city of the inhibitory mutant form of Raf was tested in the 293T cell line, where the blocking eect of this form was rescued by the presence of a constitutively active form of Raf. Raf activation is mainly due to its targeting to the plasma membrane by active Ras. Therefore we transiently transfected the TetRgr16, NIH3T3 and the 293T cell lines with RasN17 (the dominant negative form of this GTPase). As shown in Figure 9c , d and e, the transfected cells displayed the same inhibitory eect on the Rgr induced SRE activity. From these results we conclude that Rgr activates SRE Total Ral and Ras present in 10% of the lysates used for the activation assays are shown in the second and fourth panel, respectively. Rgr expression level was analysed in the same amount of lysate that was used for total GTPase levels (lower panel). The experiment was successfully repeated three times by using a pathway that is dependent on the integrity of the Ras-Raf1-MEK-ERK cascade.
On the other hand, although the response of c-Jun to Rgr was also dependent of Ral, since RalN28 impaired signi®cantly the c-Jun transcriptional activity, the expression vector cassette driving the Ras dominant negative form aected even more profoundly this eect (Figure 10a,b) . The results presented above indicate that the dominant negative form of Ras exerts the more profound inhibitory eect on the Rgr induced activation of SRE and c-Jun, and suggest that the Ras mediated pathway is essential for these eects, although to produce the full phenotype at least three small GTPases, Ras, Ral and Rho, are necessary.
In order to assure that these signaling pathways contribute not only to the transcriptional activation but also to the transforming properties of Rgr, we studied the ability of the oncogene to form foci in the presence of PD98059 and SB203580, two speci®c inhibitors of MEK and p38 MAPK, respectively. Whereas SB203580 only reduced the foci size, the MEK inhibitor almost completely abrogated Rgr foci formation (Figure 11a ). This result indicates that MEK activation is necessary for the transforming eects of Rgr.
As we had seen before that Ral and Ras mediated pathways are involved in the Rgr-induced SRE activation, we next investigated whether MEK-ERK activation by Rgr is dependent upon any of these two GTPases. To this end, 293T cells were transfected with the Rgr expression vector alone or concomitantly with expression vectors carrying the dominant negative forms of Ral or Ras. As Figure 11b shows, the Ral dominant negative form was unable to block the phosphorylation of ERK, although it succeeded before in blocking the induction of the SRE and c-Jun by Rgr. However, the corresponding dominant negative form of Ras was able to abrogate completely the Rgrinduced phosphorylation or ERK.
To further con®rm that Ral activation is not necessary for the transforming eects induced by Rgr, we performed a foci assay in which NIH3T3 cells were transfected with the Rgr expression vector alone or with the dominant negative form of Ral. This (upper left) or with Rgr (the other three plates) and 24 h later they were split and maintained in DMEM plus 5% calf serum without inhibitors (upper plates), with PD98059 (25 mM) (bottom left) or with SB203580 (10 mM) (bottom right) for 2 weeks. (b) 293T cells were transfected with the empty vector, Rgr expression vector, or with Rgr plus the dominant negative forms of Ral or Ras GTPases. 48 h later cells were recovered and lysed, and the activation state of ERK was assessed by SDS ± PAGE experiment showed that Rgr was able to form foci even in the presence of this mutant (39+6 vs 37+3 foci/ 100 ng Rgr expression vector, without or with RalN28, respectively).
All these results underscore the important role of Ras in the Rgr transforming properties.
Rgr activates the Ras-Raf-MEK-ERK pathway downstream of the EGF receptor
The GTP-bound form of Ral interacts with RalBP, a GAP for the Rho-like GTPases Cdc42 and Rac. RalBP forms also a complex with two related proteins, Pob1 and Reps. These proteins have a RalBP-binding domain that can interact with the SH3 domains of Grb2 and Crk, and an Eps15 homology (EH) domain. Upon EGF stimulation, Pob1 and Reps1 are tyrosine phosphorylated and Pob1 was found to complex with the EGF receptor, presumably through the Grb2 adaptor protein. To rule out that the activation of this loop is responsible for the observed increase in Ras activity, we proceeded to analyse this possibility by transfecting 293T cells with Rgr alone, or with Rgr and two dierent dominant negative forms of Grb2. As negative and positive controls for the speci®city of the Grb2 dominant negative forms we also transfected 293T cells with expression vectors carrying RasV12 (the constitutively active form of Ras) and v-Src. As Figure 12 shows, the phosphorylation of ERKs induced by Rgr and by Ras were insensitive to the dominant negative forms of Grb2, whereas Src-induced phosphorylation of ERKs was completely abrogated. This result suggests that Rgr is activating Ras by a mechanism in which elements acting upstream of Grb2 are not involved.
Discussion
Rgr is a 5'-truncated oncogene previously isolated in our laboratory by its ability to produce tumors in the nude mice assay (D'Adamo et al., 1997) . It belongs to the GEF family, also called GDP-dissociation stimulator (GDS) family, because it has speci®c exchange activity for Ral. Rgr has signi®cant homology to RalGDS (Ral guanine dissociation stimulator), a molecule that has been shown to be an eector of Ras and that may functionally link Ras with Ral (White et al., 1996) . However Rgr lacks the Ras-interacting domain present in the carboxyterminal end of the other RalGDS family members (D'Adamo et al., 1997). The ®rst aim of this work has been to characterize the oncogenic properties of Rgr-expressing cells. We have established four NIH3T3 ®broblast cell lines expressing Rgr driven by a tetracycline-repressible promoter. These cell lines were monitored for rgr expression and for their response to tetracycline treatment. These experiments demonstrated that the inhibition of the expression of rgr is dependent on the presence of tetracycline in the medium. Using this system, we showed that rgr expression can promote potent malignant transformation and causes a transformed phenotype. This change in cell morphology was accompanied with the appearance of a stress actin ®ber network, loss of contact inhibition, an increase in the cell culture density, and a strong cell proliferation response. Although Rgr scored negative in the focus forming assay in our previous experiments (D'Adamo et al., 1997), we succeeded in producing foci by driving Rgr under the control of a stronger promoter. These data indicate that overexpression can be responsible for some of the Rgr oncogenic properties. Since the phenotypes of cells bearing mutations in Cdc25, Sdc25 and Sos genes suggest that this family of GDS proteins may be activated by mutations, including truncation (Aronheim et al., 1994; Quilliam et al., 1995) , the role of the previously described Rgr 5' end truncation (D'Adamo et al., 1997) cannot nevertheless be ruled out as activation mechanism for this oncogene.
Transcriptional effects of Rgr
Rgr stimulated the transcriptional activity of the SRE, a regulatory element of the c-fos promoter. This eect is consistent with previous reports that demonstrated that members of the subfamily of GEFs for Ral are able to induce c-fos promoter activity (Wolthuis et al., 1997; Goi et al., 1999) . However, Ral gave little, if any, activation of the c-fos promoter by itself (Murai et al., 1997; Wolthuis et al., 1997) . To explain this apparent paradox it has been proposed that Ral may need to cycle between the GTP-and GDP-bound form for proper functioning . Precedent exists with the exchange mutant of Cdc42. Only this mutant (and not the constitutively active form of it) is able to display activity similar to Dbl, a speci®c Cdc42 exchange factor (Lin et al., 1997) . Alternatively, it is also likely that RalGEFs stimulate other molecules besides Ral in order to stimulate c-fos promoter.
Overexpression of Rgr is also associated with an increase in c-Jun mediated transcriptional activity. In this regard, Ral could modulate this activity by acting through its eector RalBP1, a GTPase-activating protein for Cdc42 and Rac1 with unknown function. Theoretically, Ral could bind RalBP1 and thus induce Figure 12 Rgr activates Ras-Raf-MEK-ERK cascade by a mechanism generated downstream of Grb2. 293T cells were transfected with empty vector, or with Rgr, activated Ras or v-Src expression vectors, alone or in the presence of two dierent dominant negative forms of Grb2. Cells were harvested and lysed, and ERK activation was analysed its GAP activity on Cdc42 and Rac, or by contrast, it could act by sequestering RalBP1, leading to the activation of these two small GTPases. Supporting this possibility, it has been reported that the Drosophila Ral GTPase regulates cell shape changes through the JNK pathway (Sawamoto et al., 1999) .
Rgr activation of Ras
When we analysed the pathways activated by Rgr we observed that not only JNK, but also p38 and ERK were activated by Rgr. It has been reported that the Ras eector domain mutant RasV12G37, which activates endogenous RalGEFs, but does not speci®-cally couple to any of the other known Ras eectors, or the active form of Rlf, that directly activates the endogenous Ral, fail to induce increases in ERK activity (Verheijen et al., 1999) . Since both mutants lead to the cycling of Ral, the increase in the phosphorylation of ERK induced by Rgr must be due to the activation of a molecule dierent than Ral. This result also suggests that Rgr is acting in a manner dierent from the other Ral GEFs, since none of them has been shown to activate ERK.
The activation of Ral by Rgr in vitro was previously reported (D'Adamo et al., 1997), and we con®rm that this activation also takes place in vivo. In this study we also demonstrate that Rgr is able to induce a potent Ras activation in vivo, although this activation was undetectable in vitro (D'Adamo et al., 1997). Since we do not know yet if Rgr interacts with Ras to activate it, the dierences in the results obtained from the in vitro and in vivo assays may respond to limitations of the in vitro assay depending on a direct or indirect activation of Ras by Rgr. In a direct model of activation, it is possible that the posttranslational modi®cations of any of the proteins (Ras or Rgr) increase the anity of Rgr for this GTPase. It has been reported that RalGDS and Rgl stimulate the GDP/ GTP exchange of the modi®ed form of Ral more eectively than that of the unmodi®ed form (Murai et al., 1997) . Besides, although RalGDS family members seem to display a high speci®city for Ral, other GEFs are able to activate dierent GTPases of the same family (Day et al., 1998) . Ral has 55% sequence identity with Ras (Chardin and Tavitian, 1989) , and both GTPases have comparable nucleotide binding characteristics and low intrinsic GTPase activity. This high structural and functional homology can account for the Rgr induced Ras activation. In an indirect model of activation, Rgr could require the presence of an adapter molecule (not present in the in vitro assay) in order to activate Ras. Ongoing investigations are directed to analyse if Rgr activates Ras by an interaction through its exchange domain or, on the contrary, if it is doing so through a dierent domain. There is precedent for multiple functions residing in GEFs. For example, SOS facilitates the exchange of nucleotides on Ras and couples Ras to Rac through its Dbl and pleckstrin homology (PH) domains in a PI3K dependent manner (Nimnual et al., 1998) .
Different pathways mediate Rgr effects
The analysis of the contribution of the dierent pathways to the cellular phenotype, the transcription and the transformation reveals that three GTPases, Ras, Ral and Rho are necessary in order to achieve the full transcriptional activation. This result agrees with reports that link Rho small GTPases with the activation of the serum response element (SRE) in an apparently JNK-and p38-independent manner (Hill et al., 1995; Westwick et al., 1997) . A hierarchical cascade for Cdc42, Rac and Rho had been postulated in Swiss 3T3 ®broblasts wherein Cdc42 activates Rac, which in turn activates Rho (Nobes and Hall, 1995) . This mechanism could explain the induction of Rho pathways by Rgr. However, only Ras activation, and the consecutive induction of the Raf-MEK-ERK cascade, is essential for the Rgr induced transformation. Our results contrast with those reported by Goi et al. (1999) . These authors, in a PC12 cell dierentiation model, observed that the dominant negative form of Ral inhibited fos induction by Rgr, but RasN17 did not. This apparent discrepancy with our results can be explained by dierent postranslational modi®cations of Ras or Rgr, or by the presence of the suggested adapter protein (in the direct or indirect Ras activation model, respectively) in our completely dierent biological system.
It has been suggested that Ral could be involved in endocytosis and/or EGF receptor downregulation that could lead to the activation of Ras (Bos, 1998) . In the proposed model, the activation of Ral leads to the formation of a complex between RalBP1 and Pob1 or Reps, two related proteins that can interact with the SH3 domains of Grb2 and Crk, feeding a reactivating signal from upstream (Yamaguchi et al., 1997; Ikeda et al., 1998) . In our studies, the dominant negative form of Ral was unable to block completely Rgr eects, and therefore, this could not be the mechanism that Rgr uses to activate Ras. Although it is formally possible that the Ral mutant was not eectively blocking the Ral pathway, it has been reported that the same dominant negative form is able to inhibit other Ral GEFs functions (Goi et al., 1999; Verheijen et al., 1999) . The function of the Ral pathways is still largely elusive, and therfore, the possible readouts to analyse an eective blockade of this pathway are dicult to ®nd. To rule out the possibility of the Ras activation by this feedback loop, we interrupted it at a level in which we could test the eectiveness of the blockade. The introduction of two Grb2 dominant negative forms did not prevent ERK phosphorylation by Rgr, whereas both dominant negative forms succeeded blocking the phosphorylation induced by Src, a nonreceptor tyrosine kinase that activates this pathway upstream of Grb2.
Finally, we would like to emphasize the notion that Rgr might be a special member of the RalGDS family. Whereas the other members of the family interact with Ras through their Ras binding domain, undergo conformational change, and translocated to the plasma membrane , Rgr lacks the Ras binding domain (at least, in the 5'-truncated known form) and, moreover, it is able to activate Ras. Localization studies of Rgr are in progress to further analyse the physiological function of this interesting and unusual GEF.
In summary, we have demonstrated that Rgr is a potent oncogene that utilizes multiple pathways to mediate its complex array of functions. Our studies show that Rgr requires functional Ras, Ral and Rho GTPases to stimulate proliferation, cell transformation and gene expression and they provide evidence for the pivotal role of Rgr in dierent signal transduction pathways involved in cell transformation.
Materials and methods
Cell culture
NIH3T3 cells were grown in DMEM supplemented with 10% calf serum, penicillin (50 units/ml), and streptomycin (50 mg/ ml) at 378C. Cell number after trypsinization was determined using a haemocytometer. All the experiments were carried out in the presence of 10% calf serum, unless indicated.
Plasmids
Rgr was subcloned into the pMEXneo expression vector (Martin-Zanca et al., 1989) . A plasmid expressing Rgr protein controlled by a hybrid element containing the tet operator and a cytomegalovirus minimal promoter was obtained by subcloning the cDNA into a neomycin pUHD10-3 vector (Gossen and Bujard, 1992) . SRE-Luc (Alexandropoulus and Baltimore, 1996) , pZIPneo-RasN17 (the dominant interfering p21 ras mutant) (Feig and Cooper, 1988) , pRSV-RafC4B (Raf-1 dominant negative expression vector) (Kerkho et al., 1998) , pRSV-RafBXB (carrying the constitutively active Raf-1 form) (Whitehurst et al., 1995) , pMKK MANA (MEK-1 dominant negative expression vector) (Cowley et al., 1994) , pZIPRhoA19N (RhoA dominant negative expression vector) , pCMV5-KRERK1 and pCMV5-K52RERK2 (ERK1 and ERK2 dominant negative forms) (Westwick et al., 1994) , pGal4-Jun (encoding the Gal4-Jun fusion protein), pG5E1b-Luc (reported plasmid that contains ®ve Gal4 sites) (Gupta et al., 1995) , pMT2-HA-RalN28 (Ral dominant negative) (Wolthuis et al., 1997) , pRK5 Grb2P49L and pRK5 Grb2R86K (dominant negative forms with SH3 and SH2 mutated domains, respectively) (Skolnik et al., 1993; Lowestein et al., 1992) , pMVSrc (Johnson et al., 1985) , pGEX4T3-GST-RalBD, pGEX4T3-GST-RBD (Wolthuis et al., 1998a) and pSG5-H-RasV12 (activated Ras) (RodriguezViciana et al., 1997) were described previously.
Transfections and luciferase assays NIH3T3 cells were transfected by the calcium phosphate precipitation method (Wigler et al., 1978) . Cell lines that expressed the tetracycline-sensitive transactivator (tTA) and Rgr were established by cotransfection of a hygromycin tTA expression plasmid pUHD15.1 (Gossen and Bujard, 1992) and the neomycin pUHD10.3-Rgr. Clones showing repression by tetracycline were selected and maintained in DMEM/ 10% calf serum supplemented with 400 mg/ml G418 and 50 mg/ml hygromycin. The relative expression level of Rgr was determined by Northern blotting. For the focus forming assay, cells were split 24 h afer the transfection and maintained in DMEM plus 5% calf serum for 2 weeks. Transient transfection assays used 3 mg of reporter plasmid, 2 mg of expression vector (if used) and 0.4 mg of pCH110 (a b-galactosidase plasmid as an internal control of transfection eciency) (Pharmacia-LKB Biotechnology). The amounts of DNA transfected in each experiment were kept constant (generally, 8 mg) by adding control plasmids. After transfection (12 ± 16 h), the cells were incubated in DMEM plus 10% calf serum for 24 h. Cell extracts and luciferase assays were subsequently performed. Transfection eciencies were normalized by b-galactosidase activity.
Northern analysis
Total RNA was extracted as described (Chomczynski and Sacchi, 1987) . After separating samples by electrophoresis on 1% denaturing formaldehyde agarose gel, RNAs were transferred to nylon ®lters. Blots were hybridized at 428C for 12 h to a 32 P-randomly primed Rgr cDNA probe. After the hybridization, ®lters were washed three times in 26SSC, 0.1% SDS at room temperature, and twice in 0.16SSC, 0.1% SDS at 658C. Filters were exposed to X-ray ®lms at 7708C.
Analysis of DNA content with flow cytometry
About 10 5 cells from each sample were collected and washed twice with ice-cold PBS, ®xed in 70% ethanol, and stored at 48C until analysis. The cells were stained with propidium iodide (50 mg/ml), treated with DNase-free RNase (10 mg/ml), and subjected to DNA content analysis using a¯ow cytometer. A minimum of 10 000 cells were counted for each sample.
Immunofluorescence analyses
For visualization of actin stress ®bers, cells were plated on coverslips and serum starved for 24 h. Cells were ®xed in 3.7% formaldehyde in phosphate-buered saline for 7 min, washed in Tris-buered saline (150 mM NaCl, 50 mM TrisHCl pH 7.6, 0.1% sodium azide), and permeabilized with 0.5% Triton X-100 in Tris-buered saline for 6 min. Polymerized actin was stained with 600 mU of tetramethyl rhodamine isothiocyanate-phalloidin per ml (Molecular Probes, Inc., Eugene, OR, USA).
Western blot analysis
SDS ± PAGE and immunoblotting were performed as described previously (Mangues et al., 1998) . Brie¯y, cellular proteins (50 mg/lane) were separated on a 7.5 or 12.5% SDSpolyacrylamide gel and transferred to a nitrocellulose membrane. The membranes were blocked with TBS-T containing 5% dry milk at 48C overnight. Phosphorylated kinase forms were probed with rabbit polyclonal anti-ACTIVE antibodies (Promega) and then treated with HRPconjugated secondary antibody. Immunoreactive proteins were visualized using the ECL Western blotting detection system (Amersham Life Sciences, Inc.). The antibody recognizing both active and inactive forms of ERK1 and ERK2 was from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Ras and Ral activation assays
The GST-tagged forms of the Raf1-Ras binding domain (RBD) and the RalBP-Ral binding domain (RalBD) were isolated from isopropyl-b-D-thiogalactopyranoside (IPTG)-induced bacteria. Cells were lysed in a buer containing 10% glycerol, 1% Nonidet P-40, 50 mM Tris-HCl (pH 7.4), 200 mM NaCl, 2.5 mM MgCl 2 , 1 mM phenylmethylsulfonyl uoride, 1 mM leupeptin, 10 mg soybean trypsin inhibitor per ml and 0.1 mM aprotinin. Lysates were clari®ed by centrifugation and the supernatants of each sample were incubated with 15 mg of GST-RBD or GST-RalBD precoupled to gluthatione beads. Samples were incubated for 2 h at 48C. Beads were washed four times in the lysis buer (de Rooij and Bos, 1997; Franke et al., 1997) .
Generation of the polyclonal Rgr antibody
A cDNA fragment corresponding from nucleotide 800 to the end of the gene was subcloned into the recombinant baculovirus vector pBlueBacHis2B (Invitrogen). The authenticity of the cDNA was con®rmed by DNA sequencing.
Recombinant baculoviruses were produced by cotransfecting Spodoptera frugiperda Sf9 cells with the Rgr transfer vector and linear AcMNPV DNA (Invitrogen) and puri®ed by plaque assay. Recombinant protein was produced by infecting Trichoplusia ni High Five cells (Invitrogen). Three days after the infection cells were harvested, washed with phosphate buered saline, and lysed. Rgr protein was puri®ed by SDS gel electrophoresis, after the identi®cation of the band corresponding to the fusion protein by Western blot using the Anti-Xpress antibody (Invitrogen). Gel slices containing 100 mg of the 55 kDa fusion protein Rgr were injected into Guinea pigs (Pocono Rabbit Farm & Laboratory, Canadensis, PA, USA). Sera were collected and stored at 7208C. Further puri®cation of the IgG fraction from the guinea pig sera was performed by using protein A-Sepharose column, following the manufacturer's instructions (Pharmacia, Piscataway, NJ, USA).
